Please login first

Medicina Webinar | Multimodal Approaches in Oligometastatic Genitourinary Cancer: What’s the Optimal Balance?

25 November 2025, 15:30 (CET)

Registration Deadline
25 November 2025

Oligometastatic disease, Genitourinary cancer, Multimodal therapy, Patient selection, Treatment sequencing, Prostate cancer, Kidney cancer, Bladder cancer
Bookmark
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Event Registration Contact Us

Welcome from the Chair

The concept of oligometastatic disease has transformed the therapeutic landscape of genitourinary cancers, offering new opportunities for durable control and even cures in selected patients. As our understanding of tumor biology deepens and imaging becomes more sensitive, the boundaries between localized and metastatic disease continue to blur. This webinar, “Multimodal Approaches in Oligometastatic Genitourinary Cancer: What’s the Optimal Balance?”, will explore how to integrate systemic and local treatments—surgery, radiotherapy, and novel systemic agents—in a patient-centered, evidence-based manner. Through expert discussion and clinical insights, we’ll address how to define optimal patient selection, timing, and treatment sequencing to achieve the best oncological and quality-of-life outcomes.

Date: 25 November 2025
Time: 3:30 pm CET | 9:30 am EST
Webinar ID: 825 1539 8301
Webinar Secretariat:
journal.webinar@mdpi.com

Event Chairs

Hospital Clínico San Carlos de Madrid, Madrid, Spain

Introduction
Talk
Simone Ferrero obtained his specialization in Gynecology and Obstetrics at the University of Genoa (Genoa, Italy) and the title of Doctor of Philosophy (Ph.D.) at Queen Mary Hospital (London, UK). He is currently an Associate Professor of Gynecology and Obstetrics at the University of Genoa, and works at IRCCS San Martino Policlinic Hospital (Genoa, Italy). Simone Ferrero is the author of over 400 publications in scientific journals indexed in PubMed with impact factors. He has already been an editor of international books about benign gynecological diseases, and he is a member of several editorial boards of international gynecological journals.
Bio
Prof. Juan Gómez Rivas is a urologist at the Hospital Clínico San Carlos in Madrid, Spain and associate professor at the Complutense University of Madrid. He received his medical degree in 2007, became urologist in 2015 and presented his PhD in 2017. He has an extensive specialised training, including a master’s degree in Comprehensive Medical and Surgical Management of Localised, Advanced and Metastatic Kidney Cancer and Prostate Cancer. His healthcare activity is focused on the field of genitourinary tumours, from localised disease to advanced stages, covering both medical and surgical management in its different approaches (open, minimally invasive, robotic, focal) of prostate, kidney and bladder cancer, among others. He is speaker and director of numerous courses at national and European level. Prof. Juan Gómez Rivas is active in several scientific societies such as the European Association of Urology (EAU) and the Spanish Association of Urology (AEU). He participates in research as a member of the Health Research Institute of the Hospital Clínico San Carlos (IdISSC) in the area of clinical and translational research in oncology. Finally, Prof. Gómez Rivas curriculum is completed with the authorship and collaboration in more than 300 scientific publications, special editions, book chapters and has numerous participations in national and international meetings and congresses.

Keynote Speakers

Department of Medical Oncology, Hospital Clínico San Carlos de Madrid, Madrid, Spain

Introduction
Bio
Dr. Natalia Vidal is a medical oncologist specializing in genitourinary tumors at the Hospital Clínico San Carlos. Subinvestigator on more than 30 clinical trials and 20 observational studies.

Hospital Clínico San Carlos de Madrid, Madrid, Spain

Introduction
Bio
Dr. Sanmamed Salgado is currently a radiation oncologist at Clinico San Carlos Hospital (Madrid) focused on genitourinary and gynecologic malignancies using VMAT, stereotactic radiotherapy, and brachytherapy approaches. She completed her Medical Degree at Santiago de Compostela University and her Radiation Oncology specialty training in Valladolid, including 3 months at the MD Anderson Cancer Center and University of Pennsylvania Hospital in the USA. In 2017, she moved to Toronto for 2 years with the goal of improving her clinical and research skills, particularly in regard to brachytherapy, as a clinical research fellow at the Radiation Medicine Program, Princess Margaret Cancer. During this period, she obtained an Abbvie CARO Uro-Oncologic Radiation Award and an ABS Resident Grant Award. Dr. Sanmamed presented her PhD in March 2023. She is an active member in the European (ESTRO), Spanish (SEOR), and American (ASTRO) societies of radiation oncology, as well as the American Brachytherapy Society. She has co-authored publications in European Urology, BJU, Brachytherapy, and the main journals of her specialty: Radiotherapy & Oncology and IJROBP.

Consultant Urologist, Unit of Urology and Renal Transplantation Oncology Department, Careggi University Hospital

Introduction
Bio
Dr. Riccardo Campi, MD, PhD, FEBU, is a consultant urologist at the Unit of Urologic Robotic, Minimally Invasive Surgery and Renal Transplantation of Careggi University Hospital in Florence, Italy, one of the highest-volume tertiary referral cancer Centres in Italy. Dr. Campi is an active member of several national and international societies. He is a member and past Chairman (2021-2025) of the European Association of Urology EAU Young Academic Urologists YAU Renal Cancer working group and an Associate Member of the EAU Guidelines Panel on Renal Cell Carcinoma. He is also an Associate Member of the EAU Section of Oncological Urology ESOU and a Member of the Italian Society of Urology SIU Research Office. Dr. Campi is an Associate Editor of European Urology Oncology. He has authored numerous editorials and book chapters and over 350 publications in peer-reviewed journals. He serves as a reviewer and editorial board member for high-ranked journals in the field of urology. Dr. Campi has an active research portfolio in the field of urologic oncology and is actively involved in several large studies including international trials in urologic oncology. His main clinical and academic interests are renal cancer, with a special emphasis on both the diagnosis and management of localized renal masses, renal transplantation, and minimally invasive surgery. ORCID ID: http://orcid.org/0000-0001-5237-0888.

Registration

This is a FREE webinar. After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Certificates of attendance will be delivered to those who attend the live webinar.

Can’t attend? Register anyway and we’ll let you know when the recording is available to watch.

Sponsors and Partners

Organizers

Program

Speaker/Presentation

Time in CET

Prof. Dr. Juan Gómez Rivas

Chair Introduction

3:30 - 3:35 pm

Dr. Natalia Vidal

Prostate Cancer

3:35 - 3:50 pm

Dr. Noelia Sanmamed Salgado

Bladder Cancer

3:50 - 4:05 pm

Dr. Riccardo Campi

Renal Cancer

4:05 - 4:20 pm

Q&A

4:20 - 4:30 pm

Prof. Dr. Juan Gómez Rivas

Closing of Webinar

4:30 - 4:35 pm

Top